Popular Semrush tools
Domain OverviewKeyword OverviewKeyword Magic ToolKeyword GapBacklink GapBacklink AnalyticsBacklink AuditOn-Page SEO CheckerLocal SEO AuditTraffic AnalyticsStart 14-Day Free Trial
Free forever for core features. 14-day trial for premium features.
Sign UpLearn MoreStart 14-day free trial
Free forever for core features. 14-day trial for premium features.
Sign UpLearn MoreAccess More Competitor Insights Now
Analyze traffic data for top domains
helps you:
Exploding Topics readers get:
Exploding Topics readers get: A 14-day trial with full access to 55+ tools.
Website Traffic Statistics: fiercebiotech.com
Get comprehensive insights into fiercebiotech.com's online performance with key traffic metrics that reveal their digital strategy and market position.
Analyze traffic sources to optimize your marketing mix
Discover audience demographics for targeted marketing
Evaluate engagement metrics to improve user experience
Traffic and Visitor Engagement Trends: fiercebiotech.com
Monitor fiercebiotech.com’s trends against competitors with critical onsite behavior metrics. In May, fiercebiotech.com received 547.2K visits with an average session duration of 6:62. Compared to April, traffic to fiercebiotech.com has decreased by 1.85%
Organic Traffic Trends: fiercebiotech.com
Track how your competitor's organic search traffic evolves over time with monthly traffic volumes and estimated value.
Global Traffic Distribution: fiercebiotech.com
See the global distribution of visitors to fiercebiotech.com and start tapping into overlooked markets. fiercebiotech.com’s core audience is located in United States, followed by India, and Japan.
| Country | All devices | Desktop | Mobile | |
|---|---|---|---|---|
| United States | 67.80% | 371K | 59.48% | 40.52% |
| India | 6.92% | 37.9K | 57.83% | 42.17% |
| Japan | 3.99% | 21.8K | 100.00% | 0.00% |
| China | 2.85% | 15.6K | 100.00% | 0.00% |
| Korea, Republic of | 2.39% | 13.1K | 84.91% | 15.09% |
Traffic Sources by Device: fiercebiotech.com
Quickly understand where fiercebiotech.com’s traffic comes from and what devices visitors prefer to use. Desktops drive 64.17% of visits, while 35.83% come from mobile devices.
Competitors and Alternatives: fiercebiotech.com
Reveal other websites that your audience is interested in. See the list of domains users are browsing next. fiercebiotech.com’s audience also visits biopharmadive.com (128.7K), followed by biospace.com (889.6K), and firstwordpharma.com (108.2K).
| URL | Com. Keywords | SE Keywords |
|---|---|---|
| biopharmadive.com | 2.7K | 59.1K |
| biospace.com | 6.8K | 501.8K |
| firstwordpharma.com | 1.9K | 95.9K |
| endpts.com | 1.2K | 38.7K |
| medtechdive.com | 1.4K | 44.4K |
| fiercepharma.com | 2K | 123.9K |
| massdevice.com | 1.3K | 38.5K |
| pharmaceutical-technology.com | 1.4K | 51.5K |
| clinicaltrialsarena.com | 1.2K | 43.7K |
Get a 14-day FREE Semrush trial to see more
Get more requests and unlock hidden results by starting a free Pro trial now.
Get Free TrialOrganic and Paid Website Traffic: fiercebiotech.com
Monitor fiercebiotech.com's traffic trends across channels to identify market opportunities. Organic search traffic has declined by (15.68%) since last month to (145K), while paid traffic has shifted by (29.10%) to (3.1K).
Top Ranking Keywords: fiercebiotech.com
Identify the search terms generating the most traffic for fiercebiotech.com. Get comprehensive metrics including monthly search volume, CPC values, search intent, and competitive difficulty. Learn more about keywords.
| Keyword | Rank | Traffic | Volume | KD % | CPC (USD) | # of Results | Search Trend |
|---|---|---|---|---|---|---|---|
| fierce biotech | 1 | 15.3K | 6.6K | 47 | 4.46 | 44 | |
| fiercebiotech | 1 | 6.7K | 2.9K | 47 | 4.46 | 47 | |
| biotech layoffs | 1 | 2.1K | 2.9K | 23 | 0.00 | 8.4M | |
| fierce biotech layoff tracker | 1 | 1.7K | 720 | 38 | 0.00 | 0 | |
| omega therapeutics | 1 | 1.4K | 1.9K | 37 | 0.00 | 18.4M | |
| biotech news | 1 | 1.4K | 1.9K | 38 | 2.54 | 160M | |
| doge federal contract cancellations | 20 | 1.2K | 135K | 33 | 0.00 | 57.2K | |
| cue health | 1 | 1.1K | 2.9K | 50 | 0.00 | 94.9M | |
| nitromed | 1 | 928 | 1.3K | 20 | 0.00 | 44 |
Get a 14-day FREE Semrush trial to see more
Get more requests and unlock hidden results by starting a free Pro trial now.
Get Free TrialReady to uncover the strategies behind your competitors’ success?
Get Free Competitor InsightsBacklink Analytics: fiercebiotech.com
Access the most comprehensive analysis of fiercebiotech.com's backlink structure with detailed metrics on domain authority, link relevance, and competitive positioning
Reveal high-authority websites linking to your competitors
Analyze competitors' link building strategies and tactics
Compare your link profile against leading competitors
Authority Score: fiercebiotech.com
Quantify website reputation and ranking potential through comprehensive metrics evaluating link quality, referring domain diversity, and competitive positioning.
Referring Domains
Track referring domain growth over the past year. Learn more about link building.
Backlinks
Track backlink growth over the past year. Learn more about backlinks.
| Backlink | Anchor Text | Nofollow | Score |
|---|---|---|---|
https://www.metatalks.ai/what-its-for-and-how-it-works-interview-with-dr-dmitrii-chebanov-on-holiverse-dna-based-avatars/↳ https://www.fiercebiotech.com/cro/altis-leads-push-digital-twins-use-trials-includes-astrazeneca-and-bayer?ref=metatalks.ai | digital twins | dofollow | 81 |
https://www.crunchbase.com/organization/roche↳ https://www.fiercebiotech.com/biotech/roche-expands-dyno-gene-therapy-collab-bets-1b-plus-ai-can-help-design-better-delivery | Roche expands Dyno gene therapy collab, bets up to $1B-plus that AI can help design better delivery tools | nofollow | 78 |
https://www.finanzen100.de/↳ https://www.fiercebiotech.com/biotech/biontech-shows-lung-cancer-survival-data-behind-phase-3-push-red-hot-bispecific | BioNTech shows off lung cancer survival data behind phase 3 push for red-hot bispecific | nofollow | 78 |
https://www.finanzen100.de/↳ https://www.fiercebiotech.com/biotech/exelixis-blockbuster-hopeful-beats-bayer-drug-pivotal-cancer-trial-sending-stock-25 | Exelixis' blockbuster hopeful beats Bayer drug in pivotal cancer trial, sending stock soaring | nofollow | 78 |
https://www.crunchbase.com/organization/biogen↳ https://www.fiercebiotech.com/biotech/chutes-ladders-biogen-boosts-c-suite-bms-vet | Chutes & Ladders—Biogen boosts C-suite with BMS vet | nofollow | 76 |
https://www.marketbeat.com/compare-stocks/pharmaceutical-stocks/↳ https://www.fiercebiotech.com/biotech/endometrial-cancer-data-genmabs-elahere-rival-beat-forecast-fuelling-push-phase-3 | Endometrial cancer data on Genmab’s Elahere rival beat forecast, fuelling push into phase 3 | nofollow | 76 |
https://www.fiercepharma.com/marketing/johnson-johnson-refreshes-positively-fearless-hiv-campaign-new-digital-presence-and-lgbtq↳ https://www.fiercebiotech.com/biotech/day-job-and-a-gay-job-lgbtq-leaders-biopharma-want-those-who-look-talk-and-love-like-them | LGBTQ+ family | dofollow | 73 |
Get a 14-day FREE Semrush trial to see more
Get more requests and unlock hidden results by starting a free Pro trial now.
Get Free Trial